deltatrials
Completed OBSERVATIONAL NCT03071640

Improving Quality of Life and Function for Older Cancer Patients Receiving Radiotherapy

Improving Quality of Life and Function for Older Cancer Patients Receiving Radiotherapy. Part IC: A Prospective Observational Study

Sponsor: Norwegian University of Science and Technology

Updated 14 times since 2017 Last updated: Dec 9, 2021 Started: Feb 22, 2017 Primary completion: Aug 13, 2018 Completion: Jul 19, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cancer and Elderly and is currently completed. Norwegian University of Science and Technology leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Study Description(click to expand)

GA includes a systematic assessment of area where older people often have problems, i.e. assessment of comorbidity, medication, functional status and physical functioning, cognitive function, nutritional status, and depression. In this observational study, the assessment will be performed using well-established instruments and tests before start and after completion of radiotherapy. The patient will be followed-up by repeated assessments at week 2, 8 and 16 post treatment. Quality of life (QoL) questionnaires will be filled in by self-report at the same points in time. Follow-up data will also include information on the patients' use of health services (home-, nursing home and hospital care). Additionally available diagnostic CT scans will also be used for analyses of nutritional status and body composition. Eligible patients will be included at the Radiotherapy Unit, Innlandet Hospital Trust after having given written informed consent. A project nurse (cancer nurse) will perform the assessments at the Radiotherapy Unit, whereas follow-up assessments will be performed by community cancer nurses. All municipalities in the hospital catchment area are invited to participate in the study. The study will be conducted in co-operation with several national and international partners, including partners from the local municipalities

GA includes a systematic assessment of area where older people often have problems, i.e. assessment of comorbidity, medication, functional status and physical functioning, cognitive function, nutritional status, and depression. In this observational study, the assessment will be performed using well-established instruments and tests before start and after completion of radiotherapy. The patient will be followed-up by repeated assessments at week 2, 8 and 16 post treatment. Quality of life (QoL) questionnaires will be filled in by self-report at the same points in time. Follow-up data will also include information on the patients' use of health services (home-, nursing home and hospital care). Additionally available diagnostic CT scans will also be used for analyses of nutritional status and body composition. Eligible patients will be included at the Radiotherapy Unit, Innlandet Hospital Trust after having given written informed consent. A project nurse (cancer nurse) will perform the assessments at the Radiotherapy Unit, whereas follow-up assessments will be performed by community cancer nurses. All municipalities in the hospital catchment area are invited to participate in the study. The study will be conducted in co-operation with several national and international partners, including partners from the local municipalities

Status Flow

~Apr 2017 – ~Apr 2018 · 12 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Oct 2019 · 12 months · monthly snapshot~Oct 2019 – ~Jan 2020 · 3 months · monthly snapshot~Jan 2020 – ~Nov 2020 · 10 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Jan 2022 · 4 months · monthly snapshot~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 19 months · monthly snapshot~Jan 2026 – present · 3 months · monthly snapshot

Change History

14 versions recorded
  1. Jan 2026 — Present [monthly]

    Completed

  2. Sep 2024 — Present [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2022 — Jul 2024 [monthly]

    Completed

  5. Sep 2021 — Jan 2022 [monthly]

    Completed

Show 9 earlier versions
  1. Jan 2021 — Sep 2021 [monthly]

    Completed

  2. Nov 2020 — Jan 2021 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  3. Jan 2020 — Nov 2020 [monthly]

    Active Not Recruiting

  4. Oct 2019 — Jan 2020 [monthly]

    Active Not Recruiting

  5. Oct 2018 — Oct 2019 [monthly]

    Active Not Recruiting

  6. Sep 2018 — Oct 2018 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  7. Jun 2018 — Sep 2018 [monthly]

    Recruiting

  8. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NANone

  9. Apr 2017 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Norwegian University of Science and Technology
  • Oslo Metropolitan University
  • Oslo University Hospital
  • St. Olavs Hospital
  • Sykehuset Innlandet HF
Data source: Sykehuset Innlandet HF

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations